MoCRA Insight: Same Ingredients, Same Formula — Different FDA Interpretations
- Provision Consulting Group
- Apr 24
- 3 min read

It’s been a while since MoCRA became the law of the land. While filing Form FDA 5067 (Product Listing) is now mandatory, few truly grasp the strategy behind it.
We’ve seen too many brands treat this as a simple administrative task, only to face a nightmare of labeling issues, rejected claims, or FDA inquiries later.
Here is the reality: This isn't just a registration. It’s the very first baseline the FDA uses to decide how to regulate your product.
Read More : Form FDA 5067 - Cosmetic Product Listing
The MoCRA Hierarchy: Order Matters

MoCRA compliance isn't a one-step deal. It’s a sequence, and getting it wrong means starting from scratch.
Form FDA 5066 (Facility Registration): You register the factory and get an FEI number.
Form FDA 5067 (Product Listing): You list the product using that FEI.
Many brands try to skip to the listing without a valid FEI—a mistake that stalls the entire process. But more important than the "how" is the "what." The data you input—Product Category Codes, INCI names, and Responsible Person info—defines your regulatory identity.
This isn't an "approval." It's your official statement to the FDA. Once it's in their system, it becomes the benchmark for customs clearance and market surveillance.
3 Trap Doors in Form 5067

1. The Category Code Trap
A category code isn’t just a label; it’s a legal boundary. If you list a basic moisturizer under a "treatment" code but market it for "cell regeneration," you’re inviting the FDA to reclassify your cosmetic as a drug.
The stakes are highest for:
Sunscreens: Anything with an SPF claim is an OTC Drug.
Acne Care: Ingredients like Salicylic Acid trigger Drug status.
Brightening: The line between "glowing skin" and "skin bleaching" is razor-thin.
2. The INCI Identity Crisis
The FDA system doesn't recognize internal supplier codes or proprietary raw material names. If it’s not an official INCI name, it’s a red flag. Also, "Fragrance" is no longer a catch-all; under MoCRA, transparency is the new standard.
3. The Claim Gap
If your listing says "Cosmetic" but your website screams "Anti-inflammatory" or "Restores skin structure," you have a problem. The FDA looks at the whole picture—your listing, your label, and your marketing. If they don't align, your product becomes a target.
It’s Not One-and-Done: Annual Maintenance
MoCRA requires active management. There is no "auto-renew." Any change in formulation, facility, or the Responsible Person must be updated annually. If you go radio silent, your registration becomes void.
Quick Audit: Is Your Listing Vulnerable?

[ ] Ingredients were entered using internal names instead of INCI.
[ ] The product falls under Sunscreen, Acne, or Brightening categories.
[ ] Marketing claims describe physiological effects or cellular-level changes.
[ ] Is there a mismatch between your label and your FDA contact info?
[ ] Have you skipped your annual update?
The PCG Difference: Compliance by Design
Most agencies just "submit" 5067. PCG (ProVision Consulting Group) builds a regulatory fortress.
We don't just check boxes. We verify INCI, analyze the Cosmetic-vs-OTC boundary, and audit your claims to ensure they match your listing. We don't just aim for "no errors"—we aim for zero risk.
Since MoCRA’s inception, we’ve been the strategic partner for K-Beauty’s most successful US entries. We don’t just file forms; we navigate the FDA for you.

Provision Consulting Group is a premier U.S. FDA regulatory consulting firm.
We support the registration and compliance of diverse product categories, including cosmetics,
pharmaceuticals, dietary supplements, medical devices, and food.
Beyond simple procedural agency, we provide actionable strategies and
sincere partnerships to ensure our clients grow securely in the U.S. market.
For inquiries or expert assistance, please contact us today.
CONTACT US
Office: 1-909-493-3276
Email: ask@provisionfda.com
.png)
